Can ozepic help fight alcoholism? See what the study says

The analysis published in the Jama Psychiatry magazine states that the traffic light can be allied in reducing the desire and consumption of drinks

Recently, the semaglutida, known with the commercial name Ozepic, has shown a significant potential to reduce alcohol consumption. Published in Jama Psychiatry magazine, the study revealed that the people who used drugs had a decrease in alcohol’s desire. The research was conducted by the University of Southern California and involved 48 participants with alcohol problems. Initially, these individuals were not on treatment. However, they had a high alcohol consumption, overcoming the moderate weekly limits. The careful selection of the participants ensured relevant and consistent data to evaluate the effectiveness of the drug.

Initially, divided into two groups, the study participants received semaglutida or a placebo. So, for nine weeks, the researchers analyzed the behavior of the participants. Therefore, the effectiveness of the drug has distinguished itself for its considerable reduction in alcohol consumption compared to the placebo group.

A crucial point that researchers highlight is the limited acceptance of drugs already approved for the treatment of alcoholism. However, ozepic medicines and the like have a high acceptance for its effectiveness in other health conditions. Therefore, this acceptance can be a decisive factor to increase the adhesion of patients to alcoholism, since the reduction of alcohol consumption is directly linked to positive health results.

Ozepico in Brazil

In Brazil, the traffic semaglutado was approved by the National Health Surveillance Agency in 2018. It is available in oral and injectable versions for the treatment of type 2 diabetes and obesity. However, its off-label use, that is, for purposes not specified in the package flyer, has aroused concern among the experts. Finally, Brazilian medical associations do not recommend managing the product. Alternative versions can and compromise the safety and effectiveness of the drug.

Source: Terra

Ben

Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.